| Blocking the CCL2–CCR2 axis using CCL2-neutralizing antibody is an effective therapy for hepatocellular cancer in a mouse model KY Teng, J Han, X Zhang, SH Hsu, S He, NA Wani, JM Barajas, ... Molecular cancer therapeutics 16 (2), 312-322, 2017 | 128 | 2017 |
| Argonaute CLIP defines a deregulated miR-122-bound transcriptome that correlates with patient survival in human liver cancer JM Luna, JM Barajas, K Teng, HL Sun, MJ Moore, CM Rice, RB Darnell, ... Molecular cell 67 (3), 400-410. e7, 2017 | 84 | 2017 |
| The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer JM Barajas, R Reyes, MJ Guerrero, ST Jacob, T Motiwala, K Ghoshal Scientific Reports 8 (1), 9105, 2018 | 72 | 2018 |
| Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia M Umeda, J Ma, BJ Huang, K Hagiwara, T Westover, S Abdelhamed, ... Blood cancer discovery 3 (3), 194-207, 2022 | 49 | 2022 |
| Reprogramming of glucose metabolism by zerumbone suppresses hepatocarcinogenesis NA Wani, B Zhang, K Teng, JM Barajas, T Motiwala, P Hu, L Yu, ... Molecular Cancer Research 16 (2), 256-268, 2018 | 37 | 2018 |
| A comprehensive analysis of argonaute-CLIP data identifies novel, conserved and species-specific targets of miR-21 in human liver and hepatocellular carcinoma AB Koenig, JM Barajas, MJ Guerrero, K Ghoshal International journal of molecular sciences 19 (3), 851, 2018 | 35 | 2018 |
| The m6A methyltransferase METTL3 regulates muscle maintenance and growth in mice JM Petrosino, SA Hinger, VA Golubeva, JM Barajas, LE Dorn, CC Iyer, ... Nature Communications 13 (1), 168, 2022 | 29 | 2022 |
| METTL3 regulates liver homeostasis, hepatocyte ploidy, and circadian rhythm–controlled gene expression in mice JM Barajas, CH Lin, HL Sun, F Alencastro, AC Zhu, M Aljuhani, L Navari, ... The American Journal of Pathology 192 (1), 56-71, 2022 | 28 | 2022 |
| Ibrutinib potentiates antihepatocarcinogenic efficacy of sorafenib by targeting EGFR in tumor cells and BTK in immune cells in the stroma CH Lin, KH Elkholy, NA Wani, D Li, P Hu, JM Barajas, L Yu, X Zhang, ... Molecular cancer therapeutics 19 (2), 384-396, 2020 | 21 | 2020 |
| Acute myeloid leukemias with UBTF tandem duplications are sensitive to menin inhibitors JM Barajas, M Rasouli, M Umeda, R Hiltenbrand, S Abdelhamed, ... Blood 143 (7), 619-630, 2024 | 10 | 2024 |
| Role of B cell lymphoma 2 in the regulation of liver fibrosis in miR-122 knockout mice KY Teng, JM Barajas, P Hu, ST Jacob, K Ghoshal Biology 9 (7), 157, 2020 | 10 | 2020 |
| Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines G Nishiguchi, LG Mascibroda, SM Young, EA Caine, S Abdelhamed, ... Nature Communications 15 (1), 482, 2024 | 4 | 2024 |
| Therapeutic approaches targeting splicing factor mutations in myelodysplastic syndromes and acute myeloid leukemia JW Figg, JM Barajas, EA Obeng Current Opinion in Hematology 28 (2), 73-79, 2021 | 4 | 2021 |
| Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibition KS Potts, RC Cameron, A Metidji, N Ghazale, LS Wallace, ... Cell reports 41 (11), 2022 | 3 | 2022 |
| UBTF tandem duplications in pediatric myelodysplastic syndrome and acute myeloid leukemia: implications for clinical screening and diagnosis JM Barajas, M Umeda, L Contreras, M Khanlari, T Westover, MP Walsh, ... Haematologica, 2020 | | 2020 |
